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Introduction and Objectives: In this era of evidence-based medicine and limited resources we seem obliged, on clinical 
and economic grounds, to demonstrate hat we improve not only patient survival but also the quality of patients' lives. 
This study aims to determine the impact of increasing lower limb ischaemia on quality of life (QOL) and which of three 
commonly used generic QOL instruments i the most valid, reliable, and responsive to change in patients with lower 
limb ischaemia. 
Patients and Methods: Two hundred and thirty-five patients, 144 men and 91 women, median age 68 years (range 
41-87 years) were graded according to ISCVS suggested reporting standards, i.e. 16 mild, 116 moderate and 25 severe 
claudicants; 33 patients had rest pain and 45 tissue loss. Patients completed Short Form 36 (SF36), EuroQol (EQ-5D) 
and Nottingham Health Profile (NHP) questionnaires at interview. Additional copies of questionnaires were posted to 
80 patients prior to attendance. Correlation between the two sets of responses reflects test-retest reliability. Correlation 
between domains measured by the three instruments reflects convergent and divergent validity. Kruskal Wallis ANOVA 
detected QOL changes across the whole group. Spearman Rank was used to analyse validity and reliability. Responsiveness 
was analysed using the Mann-Whitney U-test. 
Results: Increasing lower limb ischaemia confers ignificant (p<O.05) deterioration i : 
SF36 measured: physical functioning, physical role, pain, general health, vitality, social functioning and mental health. 
EQ-5D measured: mobility, self-care, usual activities, pain and anxiety~depression. 
NHP measured: energy, pain, emotional reaction, sleep, social isolation and physical mobility. 
All three instruments are significantly reliable (rs>0.7). The validity of SF36 and NHP (rs=0.68-0.78) is superior to 
EQ-5D (rs =0.37-0.7). SF36 & NHP are equally responsive to changes in physical activity and pain. SF36 and EQ-5D 
are most responsive to changes in social activity. SF36 is most responsive to changes in psychological status. 
Conclusion: QOL deteriorates markedly with increasing lower limb ischaemia. The SF36 would appear to be the most 
appropriate generic QOL analysis tool for these patients. We recommend its widespread adoption throughout Europe, 
thus providing a standardised tool for reporting eneric QOL. 
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Introduction 
Lower limb ischaemia isa common problem in Western 
countries. The measured prevalence of intermittent 
claudication is 5% in the population over 50 years, and 
the estimated incidence of critical ischaemia is 150-200 
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people per million of the population per year. 1'2 The 
overall prognosis of these patients is poor, with a 5- 
year mortality in claudicants of 12-52% and a yearly 
mortality of almost 20% in patients with critical isch- 
aemia. 3'4 Outcome measures conventionally used in 
clinical practice would seem to justify the use of sur- 
gical and radiological procedures in the management 
of these patients. However, these procedures are costly 
and their impact on patients' quality of life (QOL) has 
not been adequately assessed. All this being taken into 
account, the balance of benefit, especially in terms of 
health economics, of treating lower limb ischaemia is 
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finely poised. Perhaps, in this climate of evidence- 
based medicine and limited resources, further jus- 
tification for intervention is required. The success of 
a particular intervention should not only be based on 
an improvement in lower limb perfusion, but also on 
an improvement in the patient's overall QOL. Thus, 
QOL analysis is becoming increasingly popular as an 
outcome measure in vascular surgery, with studies 
analysing the impact of specific degrees of lower limb 
ischaemia on quality of life or the impact of specific 
interventions on QOL. 5'6 However, no study has pre- 
viously analysed the impact of increasing lower limb 
ischaemia on patient-reported QOL across the whole 
spectrum of the disease. In previous studies generic 
QOL in patients with lower limb ischaemia has been 
analysed utilising a vast array of different instruments 
including the Nottingham Health Profile (NHP), s the 
EuroQol (EQ-5D), 6 and Short Form 36 (SF36). 7'8 This 
use of different QOL instruments makes comparison 
between studies and interventions difficult. No paper 
has analysed which generic QOL instrument is most 
appropriate for use in these patients. This paper aims, 
firstly, to assess the impact of increasing lower limb 
ischaemia on patient-reported QOL across the whole 
spectrum of the disease. Secondly, we aim to make 
recommendations for the widespread adoption across 
Europe of a single generic QOL instrument for use in 
patients with lower limb ischaemia based upon va- 
lidity, reliability and responsiveness analysis. 
Materials and Methods 
This study was approved by the ethical committee of 
St James's and Seacroft University Hospitals. Over a 
period of 9 months a consecutive series of patients 
presenting to the department of Vascular and Endo- 
vascular Surgery at St James's University Hospital, 
Leeds with lower limb ischaemia were invited to 
participate in the study. Two hundred and thirty-five 
patients with varying degrees of lower limb ischaemia 
were enlisted, 144 men and 91 women with a median 
age of 68 years (range 41-87 years). The severity of 
patients' lower limb ischaemia was graded according 
to ISCVS-suggested standards for reports dealing with 
lower extremity ischaemia. 9 Sixteen patients had mild, 
116 moderate and 25 severe claudication. Thirty-three 
patients had rest pain and 45 tissue loss. Patients 
completed the SF36, EQ-5D and NHP at interview. 
Patient details for each subgroup of lower limb isch- 
aemia are shown in Table 1. 
Short form 36 
The SF36 was developed from a previous questionnaire 
known as the Medical Outcomes Study General Health 
Survey Instrument. 9 The objectives of the authors were 
to develop a general health survey which was com- 
prehensive and psychometrically sound, yet short 
enough to be of practical use in large scale studies. 
The result was a standardised generic questionnaire, 
designed for self or interview completion. It contains 
36 questions covering eight dimensions of health and 
produces ahealth profile. It is not designed to generate 
a single index or tariff of health. For each dimension, 
question scores are coded, summed and transformed 
on a scale from 0 (worst health) to 100 (best health). 
For this study the anglicised, or U.K., version of the 
SF36 was used. In population studies and in other 
patient groups, the SF 36 has been found to be ac- 
ceptable, valid, reliable and satisfies conventional psy- 
chometric riteria. 1°-I2 
EuroQol 
The EQ-5D was developed by a multi-disciplinary 
group of researchers from different European centres 
whose aims were to develop a standardised generic 
instrument o describe health-related QOL in a way 
that reflected the salient features of health as perceived 
by the general population. The capability of generating 
a single index value for each health state was also 
desired. The instrument was also designed to be in- 
terview- or self-completed and to be sufficiently brief 
to be used in conjunction with more specific in- 
struments, not as a stand-alone instrument. 13After 
initial assessment of the original six dimension in- 
strument (EQ-6D), two dimensions were combined, 
resulting in the present instrument, he EQ-5D, which 
measures five dimensions, each on three levels. The 
EQ-5D also incorporates a visual analogue scale on 
which patients are requested to rate their health on a 
scale 0 (worst imaginable health) to 100 (best ima- 
ginable health). Thus, EQ-5D generates 244 (excluding 
dead) theoretically possible health states, some of 
which are unlikely to occur in practice. Single tariffs 
or indices of health can be derived for each of these 
health states. 14 The EQ-5D has been found to be ac- 
ceptable, valid and reliable in population studies and 
other patient groups. 15'I6 
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Table 1. Patient characteristics and clinical indicators of lower limb ischaemia. 
Mild Moderate Severe Rest pain Tissue loss Kruskal Wallis 
claudication claudication claudication ANOVA 
n 16 116 25 33 45 
Median age (years) 60 67 72 67 74 p = <0.01 
Age range (years) 49, 76 41, 87 44, 86 42,82 43, 87 
Male:female ratio 13:3 78:38 12:13 19:14 22:23 
Median resting ABPI 0.81 0.65 0.52 0.44 0.3 p = <0.01 
IQR resting ABPI 0.6, 0.85 0.57, 0.75 0.44,0.58 0.19, 0.58 0, 0.4 
Table 2. Domains measured by the three instruments with "like" domains in italics. 
Domain Short Form 36 Nottingham Health EuroQol 
Profile 
Pain Pain Pain Pain~Discomfort 
Physical activity Physical functioning Physical mobility Mobility 
Usual activities 
Self-care 
Psychological status Mental health Emotional reaction Anxiety~depression 
Vitality Energy 
Emotional role 
Social activity Social functioning Social isolation (Usual activities) 
Other General health Sleep 
Physical role 
Nottingham health profile 
The NHP was developed as a measure of health that 
utilised patients' perceptions and language rather than 
medical judgements and categories. ~7It consists of two 
parts which may be used independently. Part I consists 
of 38 questions, grouped into six domains. The number 
of questions in each domain varies from three to nine. 
Scores for each domain are calculated by applying a 
weight to each question and summing the question 
scores for that domain. All scores range from 0 (the 
best possible score) to 100 (the worst possible score). 
Part 2, which was not used in this study, analyses the 
impact of health on the activities of everyday life. 
Thus, Part 1 produces a profile of health but no single 
index. It can be self- or interview-completed, and has 
been shown to be valid and reliable; its responsiveness, 
however, has been questioned. 18'~9 
Domains measured by the SF36, EQ-5D and NHP 
questionnaires are listed in Table 2. Several domains 
are common to all three questionnaires; these (in italics) 
are known as "like" domains. 
Validity is defined as "the extent to which an in- 
strument measures what it purports to measure. "2° In 
this study, we utilised convergent/divergent validity, 
a form of factor analysis (a statistical method of ana- 
lysing construct validity); i.e., the correlation between 
"like" domains should be greater than that between 
"non-like" domains. 
Reliability is defined as "the extent to which an in- 
strument yields the same results on the same popu- 
lation under different conditions. "21 Eighty patients, 
40 men and 40 women, were requested to complete 
two sets of questionnaires. The first set of ques- 
tionnaires was sent with the patient's hospital ap- 
pointment with a request o complete them that day 
at home. The second set of questionnaires were com- 
pleted i week later at interview in the vascular laborat- 
ory when the patients attended hospital. The 
correlation between the two sets of completed ques- 
tionnaires reflects test-retest reliability. 
Responsiveness, or the instrument's ability to detect 
"small but clinically significant changes", was also 
analysed. 19 
Statistical analysis 
This was performed using Microsoft Office Pro- 
fessional (Microsoft Ltd., Wharfdale Road, Winnersh 
Triangle, Wokingham, Berks, U.K.) with the Astute 
statistics add-in for Microsoft Excel (DDU Software, 
The University of Leeds, Old Medical School, Leeds, 
U.K.). Kruskall Wallis analysis of variance was used 
to analyse changes in QOL domains across the groups 
of increasing severity of lower limb ischaemia. 
Spearman rank correlation was used to assess con- 
vergent validity, divergent validity and test-retest re- 
liability. Responsiveness analysis was performed using 
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Physical Role Pain* 
function* physical* 
General Vitality* Social Mental 
health* function* health** 
Fig. 1. Variation i  Short Form 36 (SF36) quality of life domains with increasing lower limb ischaemia. Kruskal Wallis ANOVA * p<0.01, 
• *p<0.05. ( i) mild claudication; (~) moderate claudication; ([]) severe claudication; ([]) rest pain; (El) tissue loss. 
the Mann-Whitney U-test. Throughout he statistical 
analysis a p value of <0.01 was taken to represent 
statistical significance unless otherwise stated. 
Results 
Increasing lower limb ischaemia is associated with a 
reduction in the male to female ratio of patients af- 
fected, a significant increase in patients' age, and a 
significant fall in ABPI. 
Validity 
Using the analysis method outlined above, the de- 
monstration of validity requires the correlation 
between "like" domains measured by different in- 
struments to be greater than the correlation between 
non-like domains, i.e. the correlation between EQ-5D- 
measured pain and SF36-measured pain should be 
closer than the correlation between EQ-5D-measured 
pain and the other SF36-measured omains. The 
Spearman rank convergent and divergent correlation 
coefficients are summarised in Table 3. 
Quality of life results 
Increasing lower limb ischaemia results in a significant 
deterioration i SF36-measured QOL domains of phys- 
ical functioning, physical role, pain, general health, 
vitality, social functioning (p<0.01) and mental health 
(p<0.05) and all NHP-measured QOL domains, i.e. 
physical mobility, pain, energy, emotional reaction, 
sleep and social isolation (p<0.01). These results are 
shown in Figs 1 and 2. Increasing lower limb ischaemia 
also results in a statistically significant increase in the 
reported severity of the EQ-5D pain, and an increase 
in both the reported frequency and the severity of the 
domains of mobility, self-care, usual activities and 
anxiety/depression (Fig. 3). The only domain analysed 
by the three instruments which is not significantly 
adversely influenced by increasing lower limb isch- 
aemia is the SF36-measured emotional role. 
Short Form 36. The SF36, when correlated with the NHP, 
would seem a valid measurement of pain, physical 
abilities and psychological status, with convergent 
correlation coefficients exceeding divergent. However, 
when correlated with the EQ-5D the convergent cor- 
relation coefficient for pain is not as great as the 
divergent correlation coefficient for usual activities, 
and the SF36 domain of physical functioning correlates 
more closely with usual activities and self-care than 
with mobility. The correlations with the EQ-5D's psy- 
chological domains do, however, lend further support 
to the validity of the SF36 in the assessment of psy- 
chological status. 
Nottingham Health Profile. The validity of the NHP in 
the measurement of pain, physical ability and psy- 
chological status are supported by high convergent 
correlation coefficients. The NHP domain of physical 
mobility correlates more closely with usual activities 
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Social 
isolation* 
Fig. 2. Variation in Nottingham Health Profile (NHP) quality of life domains with increasing lower limb ischaemia. Kruskal Wallis 







1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
Mobility* Self-care* Usual activities* Pain* Anxiety/depression* 
Fig. 3. Variation in EuroQol (EQ-5D) domains with increasing lower limb ischaemia. Kruskal Wallis ANOVA *p<0.01.1 = mild claudication; 
2 = moderate claudication; 3 = severe claudication; 4 = rest pain; 5 = tissue loss. ([]) EQ 3; ( I )  EQ 2. 
and self-care than mobility on the EQ-5D. However, 
NHP-measured  social isolation has low convergent  
correlat ion wi th  EQ-5D-measured usual  activities and 
SF36-measured social funct ion ing and has highest di- 
vergent  correlation coefficients with EQ-5D-measured 
anx ie ty /depress ion  a d  wi th  SF36-measured menta l  
health. 
EuroQol. The validity of the EQ-5D in its measurement 
of pain, physical ability and psychological status 
would seem to be supported with convergent cor- 
relation coefficients being greater than divergent for 
the domains of pain, mobility, self care and anxiety/ 
depression. The EQ-5D domain of usual activities 
correlates best with the SF36 domains of pain, physical 
function and social functioning and with the NHP 
domains  of pa in  and physical  mobil ity. The convergent  
correlat ion coefficients of the EQ-5D are general ly 
lower ( -0 .37  to -0 .7 )  than for the SF36 and NHP 
( - 0.5 to - 0.78) 
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Table 3. Convergent (bold) and divergent correlation coefficients for domains measured by the three instruments. 
EuroQol measured Nottingham Health Profile measured 
Pain Mobility Usual Self- Anxiety/ Pain Physical Emotional Energy Social Sleep 
activity care depression mobility reaction isolation 
Short Form Pain - 0.54 - 0.30 - 0.60 0.46 - 0.30 
36-measured Physical function - 0.44 - 0.37 - 0.55 - 0.59 - 0.35 
Mental health -0.31 -0.16 -0.33 -0.31 -0.70 
Vitality - 0.32 - 0.26 - 0.45 - 0.39 - 0.46 
Emotional role -0.16 -0.27 -0.27 -0.16 -0.52 
Social functioning - 0.44 - 0.08 ( -  0.53) - 0.36 - 0.26 
General health 0.26 - 0.09 0.29 - 0.36 - 0.36 
Physical role -0.31 -0.12 -0.27 -0.33 -0.30 
Nottingham Pain 0.57 0.26 0.51 0.44 0.31 
Health Physical mobility 0.38 0.38 0.52 0.61 0.30 
Profile- Emotional reaction 0.25 0.16 0.34 0.33 0.64 
measured Energy 0.22 0.22 0.38 0.36 0.49 
Social isolation 0.16 0.18 0.27 0.39 0.43 
Sleep 0.35 0.28 0.39 0.40 0.45 
0.68 -0.64 -0.39 -0.40 -0.26 -0.46 
-0.65 -0.78 -0.44 -0.49 -0.38 -0.51 
-0 .36 -0.34 - 0.74 -0.59 0.44 - 0.41 
-0 .57 - 0.62 -0.58 -0.69 0.40 -0.47 
-0.18 -0.43 -0.50 -0.47 -0.33 -0.31 
- 0.5 - 0.52 -0.44 0.33 -0.32 -0.37 
-0.40 -0.44 -0.38 -0.40 -0.17 -0.37 
-0.46 -0.49 -0.39 -0.44 -0.21 -0.43 
Table 4. Test-retest reliability coefficients (rs) for the three instruments. 
Form 36 domains Nottingham Health Profile EuroQol domains 
rs p rs p rs p 
Physical functioning 0.88 <0.0001 Energy 0.8 <0.0001 Mobility 0.83 <0.0001 
Role physical 0.74 <0.0001 Pain 0.86 <0.0001 Self-care 0.82 <0.0001 
Pain 0.82 <0.0001 Emotional reaction 0.87 <0.0001 Usual activities 0.74 <0.0001 
General health 0.89 <0.0001 Sleep 0.86 <0.0001 Pain 0.80 <0.0001 
Vitality 0.89 <0.0001 Social isolation 0.83 <0.0001 Anxiety/depression 0.78 <0.0001 
Social functioning 0.81 <0.0001 Physical mobility 0.87 <0.0001 
Role emotional 0.7 <0.0001 
Mental health 0.88 <0.0001 
Reliability 
Of the 80 pat ients  requested to complete  two sets of 
quest ionnaires ,  59 pat ients,  33 men and 26 women,  
med ian  age 71 years  (range 44-87 years),  ful ly com- 
p le ted  both  sets of quest ionnaires.  The corre lat ion 
between the two sets of responses reflects test - retest  
re l iabi l i ty  and the results  are summar ised  in Table 4. 
A l l  domains  measured  by  all three ins t ruments  are 
stat ist ical ly rel iable, w i th  re l iabi l i ty  coefficients >0.7. 
The NHP is perhaps  the most  rel iable of the in- 
s t ruments  tested, at ta in ing rel iabi l i ty  coeff icients of 
>0.8 for all domains  analysed.  
Responsiveness 
The abi l i ty to detect  smal l  but  s ignif icant changes in 
pa in  and  phys ica l  abi l i ty between the subgroups  of 
pat ients  is equal ly  good  for the SF36 and  NHP. Both 
are able to detect  changes between the major i ty  of 
the subgroups .  None of the three quest ionnai res  are 
par t icu lar ly  respons ive  to changes in social func- 
t ioning, but  the SF36 and EQ-5D per fo rm better  than 
the NHP. The SF36 domain  of v i ta l i ty  is the most  
respons ive  of the "psycho log ica l "  domains  to changes 
in mood.  Respons iveness  of the inst ruments  is shown 
in Table 5, and  if an ins t rument  has more  than one 
measure  of a domain  the most  respons ive  measure  
has been used.  
Discussion 
The changing male  to female rat io w i th  increas ing 
lower  l imb ischaemia is an interest ing f inding wh ich  
has not  p rev ious ly  been documented  and  deserves 
further  study.  Regard ing  QOL analysis,  the Wor ld  
Hea l th  Author i ty ,  in its def in i t ion of health,  out l ines 
the p ivota l  role of physical ,  social and psycho log ica l  
wel l  being.  2R These are the key  d imens ions  ana lysed  
by  the major i ty  of gener ic QOL inst ruments ,  and form 
the basis of quest ion ing in the three inst ruments  under  
s tudy  here. There can be l ittle a rgument  hat this s tudy  
c lear ly demonst ra tes  increas ing lower  l imb ischaemia 
has a progress ive ly  det r imenta l  impact  on pat ient -  
repor ted  QOL, w i th  progress ive  deter iorat ion  i  18 of 
the 19 domains  measured  by  the three instruments .  
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Table 5. Responsiveness analysis for "like" domains measured by the three instruments. 
Domain Instrument lv2 lv3 lv4 lv5 2v3 2v4 2v5 3v4 3v5 4v5 Total 
Physical activity SF36 Physical functioning X X X X X X X NS X NS 8 / 10 
NHP Physical mobility X X X X NS X X X X NS 8/10 
EQ-5D Usual activity NS NS X X NS X X NS NS NS 4/10 
Pain SF36 Pain X X X X X X X NS X NS 8/10 
NHP Pain X X X X NS X X X X NS 8/10 
EQ-5D Pain Ns NS X X Ms X X X X NS 6/10 
Social activity SF36 Social functioning NS NS X X MS X X NS MS NS 4/10 
NHP Social isolation Ns MS NS X ~¢s NS X NS NS NS 2/10 
EQ-5D Usual activity NS NS X X Ns X X NS MS NS 4/10 
Psychological status SF36 Vitality X X X X NS X X NS NS NS 6/10 
NHP Energy NS NS X X NS X X NS MS MS 4/10 
EQ-5D Anxiety/depression NS NS MS NS NS X NS NS NS ~¢S 1/10 
x = p<O.01, NS = not significant (Marm-Whitney U-Test). 1 = mild, 2 = moderate, 3 = severe claudication, 4 = rest pain, 5 = tissue loss. SF36 = 
Short Form 36; NHP = Nottingham Health Profile; EQ-SD = EuroQo]. 
This finding may lend justification to the time and 
resources consumed in the treatment of critical isch- 
aemia. 
The only domain not influenced by increasing lower 
l imb ischaemia is the SF36-measured emotional role. 
Others have also found that this domain does not 
improve following successful treatment for lower limb 
ischaemia, 7 and it has the poorest reliability coefficient 
of all domains analysed by the three questionnaires. 
Thus, in future studies concerning patients with lower 
limb ischaemia perhaps, in the interest of brevity, this 
domain could be omitted. 
There would seem to be a "floor effect" in the 
SF36 analysis of physical role in patients with severe 
claudication, rest pain and tissue loss, i.e. they initially 
score the lowest possible score and thus further de- 
terioration cannot be registered. Also, a "ceiling effect" 
is seen in the NHP analysis of social isolation in 
patients with mild, moderate and severe claudication 
and rest pain, i.e. their initial score is the highest 
possible, and thus any improvement  will not be re- 
gistered. There does not appear to be a simple solution 
to rectify these effects without major alterations to the 
questions posed by the instruments. 
Closer inspection of the questionnaires reveals that 
the SF36 domain of physical functioning and the NHP 
domain of physical mobil ity analyse the physical ac- 
tivities of daily living rather than simple mobility. This 
being taken into account, the fact that these domains 
demonstrate better correlation with EQ-5D-measured 
usual activities and self-care than with mobil ity may 
actually support,  rather than detract from, the validity 
of these domains. 
The NHP domain of social isolation has a better 
correlation with psychological domains than with so- 
cial domains measured by the other two instruments. 
This suggests that it is measuring psychological status 
rather than social activity. If this is the case, the NHP 
does not contain a domain assessing social activity, 
and purists may argue that is therefore not com- 
prehensively analysing generic QOL. 
The EQ-5D narrowly escapes this argument due to 
the good correlation of its usual activities domain with 
the SF36 domain of social functioning. From the figures 
presented there can be little argument regarding the 
reliability of all three instruments in this specific 
patient group. The responsiveness to variations in 
physical activity and pain is excellent for both the 
NHP and the SF36. If ultra-critical, one may highlight 
the suggestion that lack of responsiveness to these 
dimensions is demonstrated by the NHP at the milder 
end of the disease spectrum and by the SF36 at the 
more severe end of the disease spectrum. The re- 
sponsiveness of the EQ-5D to these dimensions eems 
acceptable between patients with claudication and 
critical ischaemia, but poor within these broad sub- 
groups. The SF36 and EQ are the most responsive to 
changes of social activity, both only detecting dif- 
ferences between mi ld /moderate  claudication and the 
other more severe degrees of lower limb ischaemia. 
This suggests that severe claudication, rest pain and 
tissue loss have a similar impact on social activity. The 
SF36 is clearly the most responsive to changes within 
the domain of psychological status. Also of interest was 
the fact that no significant differences were apparent 
between patients suffering rest pain and critical isch- 
aemia in any of the 19 domains measured by the three 
instruments, uggesting both these conditions have an 
equally devastating impact upon health-related QOL. 
Conclusion 
There is no mystical enigma regarding QOL analysis: 
it should be treated as any other outcome measure. 
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That is to say, in order to facilitate the compar ison of 
intervent ions for the same degree of ischaemia and 
the compar ison of different centres, s tandard ised 
methods of QOL analysis should be adopted in vas- 
cular surgery and  intervent ional  radiology. It is sur- 
prising, therefore, that unl ike other outcome measures,  
no consensus tatement is available to suggest which 
is the most  appropr iate ins t rument  o use in this 
specific group of patients. 2'4'9 We wou ld  suggest that on 
the evidence of validity, rel iabil ity and  responsiveness 
analysis presented in this study, the SF36 should be 
adopted throughout  Europe as a standard ised in- 
s t rument  for report ing eneric QOL and a benchmark  
against which other ins t ruments  may be gauged. Per- 
haps the only  potent ia l  d isadvantage with adopt ing 
the SF36 for w idespread use is that, at present,  no 
single useful  index or tariff of QOL can be generated 
from it; however,  I am assured this is under  de- 
ve lopement  (J.E. Brazier, personal  communicat ion) .  
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